Clinical studies on s 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections

Seiichi Aonuma, Kotaro Oizumi, Akira Watanabe, Yutaka Tokue, Yoshihiro Honda, Reiko Ono, Naoto Kitamura, Kiyoshi Konno

    研究成果: Article査読

    抄録

    S 6472 granule preparation (sustained-release cefaclor) was orally administered to 15 patients with chronic respiratory tract infections (2 acutely exacerbated cases of chronic bronchitis, 13 cases of secondary infections consisting of 1 case of bronchial asthma, 2 cases of bronchial asthma/pulmonary emphysema, and 10 cases of bronchiectasis) at a daily dose of 750 mg de-vided into 2 doses administered after breakfast and dinner, for a duration of 14 days. The drug was ineffective in 3 of the 10 cases of bronchiectasis but was effective in the other 12 cases, with a rate of efficacy of 80^. There were no side effects or abnormal laboratory findings due to administration of this drug.

    本文言語English
    ページ(範囲)1309-1312
    ページ数4
    ジャーナルthe japanese journal of antibiotics
    41
    9
    DOI
    出版ステータスPublished - 1988 1 1

    ASJC Scopus subject areas

    • 微生物学(医療)
    • 薬理学(医学)
    • 感染症

    フィンガープリント

    「Clinical studies on s 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

    引用スタイル